Favorable vaccine-induced SARS-CoV-2–specific T cell response profile in patients undergoing immune-modifying therapies

BACKGROUND Patients undergoing immune-modifying therapies demonstrate a reduced humoral response after COVID-19 vaccination, but we lack a proper evaluation of the effect of such therapies on vaccine-induced T cell responses.METHODS We longitudinally characterized humoral and spike-specific T cell r...

Description complète

Détails bibliographiques

Auteurs principaux:	Martin Qui, Nina Le Bert, Webber Pak Wo Chan, Malcolm Tan, Shou Kit Hang, Smrithi Hariharaputran, Jean Xiang Ying Sim, Jenny Guek Hong Low, Weiling Ng, Wei Yee Wan, Tiing Leong Ang, Antonio Bertoletti, Ennaliza Salazar
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Clinical Investigation 2022-06-01
Collection:	The Journal of Clinical Investigation
Sujets:	COVID-19 Immunology
Accès en ligne:	https://doi.org/10.1172/JCI159500
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!